$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Neurodevelopmental disorders include a wide and heterogeneous group of disorders such as Down syndrome, fragile X syndrome (FXS), Rett syndrome, neurofibromatosis, tuberous sclerosis and ASD, in which the development and maturation of the central nervous system (CNS) is disturbed early during the prenatal period1. These developmental brain dysfunctions can cause profound, lifelong effects on motor function, language, learning and memory process. A plethora of genetic and environmental factors have been implicated in the pathogenesis of neurodevelopmental disorders during the last few years2,3. Even if the molecular mechanisms underlying the clinical phenotype remain unknown, the above mentioned findings have allowed the development of several mouse models of these disorders. Learning and memory deficits have been identified in a number of these mouse models such as Tsc1+/-, Tsc2+/-, Nf1+/- and En2-/- mice2,4-7. An important challenge in the field of neurodevelopmental disorders is the identification of cellular and molecular processes underlying memory and learning dysfunction. Selected signaling pathways activated during learning or memory can induce the transcription of specific genes and ultimately lead to de novo protein synthesis. Immediate-early genes (IEGs) activation and protein-dependent synaptic modifications are rapidly induced in brain neurons in response to neuronal activity and behavioral training8,9.
Deficits in signaling pathways involving neurofibromin have been associated with impaired learning in neurodevelopmental disorders. Neurofibromin is the product of the NF1 gene, whose mutation causes neurofibromatosis type 1, a complex genetic syndrome characterized by nervous system tumors, behavioral and motor delays, and cognitive disabilities10. Mice heterozygous for Nf1 deletion restricted to inhibitory neurons show deficits in the early phase of long-term potentiation (LTP), as well as compromised spatial learning in MWM5,11,12. Interestingly, Nf1 deficiency in this mouse model leads to an over-activation of Ras signaling in inhibitory interneurons during learning, resulting in increased ERK phosphorylation and finally in an abnormal enhancement of GABA release from these neurons5.
Based on these findings, the visualization of neuronal activity after behavioral tasks represents a way to reconstruct specific circuits involved in neurodevelopmental diseases. The immunohistochemistry protocol described here aims to assess and quantify hippocampal ERK phosphorylation levels following MWM in an ASD mouse model with cognitive deficits. MWM is widely used to investigate hippocampal dependent spatial learning and memory in rodents13,14. We decide to use ERK phosphorylation as molecular readout of task-dependent hippocampal learning, since ERK was shown to have an essential role in learning and memory formation15. Moreover, the ERK pathway is necessary for experience-dependent plasticity in the developing visual cortex16. Finally, mice lacking one of the two ERK isoforms (ERK2) in the CNS show marked anomalies in cognitive, emotional and social behaviors17, indicating that ERK signaling might play a critical role in the pathogenesis of neurodevelopmental disorders such as ASD.
We used Engrailed 2 knockout (En2-/-) mice as a model of neurodevelopmental disorders. En2-/- mice show anatomical and behavioral “ASD-like” features, including loss of forebrain interneurons18, reduced expression of ASD-related genes19, decreased sociability, and impaired cognitive flexibility6,7,20. Spatial learning and memory defects, such as those detected in MWM, are especially robust in En2-/- mice6,7 and might be relevant to the cognitive impairments observed in ASD patients21. Furthermore, we showed that impaired spatial learning in MWM is associated with reduced neurofibromin expression and increased pERK levels in the hilus of En2-/-adult mice7. Here we present the detailed protocol for the immunohistochemical characterization of pERK following MWM in this ASD mouse model.